Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer

T C Thompson1, S H Park, T L Timme

  • 1Department of Urology, Baylor College of Medicine, Houston, Texas.

Oncogene
|March 2, 1995
PubMed

Insights

Loss of p53 tumor suppressor gene function accelerates prostate cancer development and metastasis in mice. This study highlights p53

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Tumor suppressor genes, like p53, are critical in preventing cancer.
  • Oncogenes (e.g., ras, myc) drive cell growth and can initiate cancer.
  • Understanding their interactions is key to cancer research.

Purpose of the Study:

  • To investigate how p53 gene status affects cancer progression when oncogenes are activated.
  • To model prostate cancer development and metastasis using the mouse prostate reconstitution (MPR) system.

Main Methods:

  • Utilized p53 'knockout' mouse urogenital sinus tissue.
  • Employed retroviral transduction of ras and myc oncogenes within the MPR model.
  • Analyzed tumor formation, metastasis, and p53 allele status.

Main Results:

  • Wild-type p53 mice showed hyperplasia but limited cancer.
  • p53 mutant mice (heterozygous and homozygous) developed prostate cancer in 100% of cases.
  • Metastasis to lung, lymph nodes, bone, and liver occurred in 95% of p53 mutant mice.
  • Cancer progression correlated with loss or deletion of the wild-type p53 allele.
  • Metastases did not always originate from the dominant clone in primary tumors.

Conclusions:

  • p53 loss significantly promotes prostate cancer initiation, progression, and metastasis.
  • The loss of wild-type p53 function is a critical event in advanced prostate cancer.
  • Metastatic seeding may involve minor clones within the primary tumor.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...